0000000000175568

AUTHOR

Jack C. De La Torre

showing 5 related works from this author

Hemodynamic Instability in Heart Failure Intensifies Age-Dependent Cognitive Decline

2020

This review attempts to examine two key elements in the evolution of cognitive impairment in the elderly who develop heart failure. First, major left side heart parts can structurally and functionally deteriorate from aging wear and tear to provoke hemodynamic instability where heart failure worsens or is initiated; second, heart failure is a major inducer of cognitive impairment and Alzheimer's disease in the elderly. In heart failure, when the left ventricular myocardium of an elderly person does not properly contract, it cannot pump out adequate blood to the brain, raising the risk of cognitive impairment due to the intensification of chronic brain hypoperfusion. Chronic brain hypoperfus…

0301 basic medicineAortic valveAgingCardiac outputmedicine.medical_specialtyHemodynamicsHeart Part03 medical and health sciences0302 clinical medicineInternal medicineMitral valvemedicineAnimalsHumansCognitive DysfunctionCognitive declineAtrium (heart)Heart Failurebusiness.industryGeneral NeuroscienceHemodynamicsBrainGeneral Medicinemedicine.diseasePsychiatry and Mental healthClinical Psychology030104 developmental biologymedicine.anatomical_structureHeart failureCardiologyGeriatrics and Gerontologybusiness030217 neurology & neurosurgeryJournal of Alzheimer's Disease
researchProduct

Deciphering Alzheimer’s Disease Pathogenic Pathway: Role of Chronic Brain Hypoperfusion on p-Tau and mTOR

2021

This review examines new biomolecular findings that lend support to the hemodynamic role played by chronic brain hypoperfusion (CBH) in driving a pathway to Alzheimer’s disease (AD). CBH is a common clinical feature of AD and the current topic of intense investigation in AD models. CBH is also the basis for the vascular hypothesis of AD which we originally proposed in 1993. New biomolecular findings reveal the interplay of CBH in increasing tau phosphorylation (p-Tau) in the hippocampus and cortex of AD mice, damaging fast axonal transport, increasing signaling of mammalian target of rapamycin (mTOR), impairing learning-memory function, and promoting the formation of neurofibrillary tangles…

0301 basic medicineHippocampustau ProteinsDisease03 medical and health sciences0302 clinical medicineAlzheimer DiseasemedicineAnimalsHumansCognitive declinePI3K/AKT/mTOR pathwayCerebral hypoperfusionbusiness.industryTOR Serine-Threonine KinasesGeneral NeuroscienceNeurodegenerationBrainGeneral Medicinemedicine.diseaseCortex (botany)Psychiatry and Mental healthClinical Psychology030104 developmental biologyCerebrovascular CirculationAxoplasmic transportGeriatrics and GerontologybusinessNeuroscience030217 neurology & neurosurgeryJournal of Alzheimer's Disease
researchProduct

The FDA Approves Aducanumab for Alzheimer's Disease, Raising Important Scientific Questions1.

2021

medicine.medical_specialtyDrug Industrybusiness.industryGeneral NeuroscienceMEDLINEGeneral MedicineDiseaseAntibodies Monoclonal HumanizedRaising (linguistics)United StatesPsychiatry and Mental healthClinical PsychologyAlzheimer DiseaseMedicineHumansAducanumabGeriatrics and GerontologybusinessIntensive care medicineDrug ApprovalJournal of Alzheimer's disease : JAD
researchProduct

Function of Glia in Aging and the Brain Diseases.

2019

Microglia cells during aging, neurodegeneration and neuroinflammation show different morphological and transcriptional profiles (related to axonal direction and cell adhesion). Furthermore, expressions of the receptors on the surface and actin formation compared to young are also different. This review delves into the role of glia during aging and the development of the diseases. The susceptibility of different regions of the brain to disease are linked to the overstimulation of signals related to the immune system during aging, as well as the damaging impact of these cascades on the functionality of different populations of microglia present in each region of the brain. Furthermore, a decr…

AgingDiseaseReviewBiologyBlood–brain barrier03 medical and health sciences0302 clinical medicineImmune systemmedicineHumansCell adhesionReceptorNeuroinflammationBrain DiseasesMicrogliaglia.NeurodegenerationBrainGeneral Medicinemedicine.diseasemedicine.anatomical_structureGene Expression RegulationBlood-Brain Barrier030211 gastroenterology & hepatologyMicrogliaNeuroscienceNeuroglia
researchProduct

Can mild cognitive impairment be stabilized by showering brain mitochondria with laser photons?

2019

There is now substantial evidence that cerebral blood flow (CBF) declines with age. From age 20 to 60, CBF is estimated to dip about 16% and continues to drop at a rate of 0.4%/year. This CBF dip will slowly reduce oxygen/glucose delivery to brain thus lowering ATP energy production needed by brain cells to perform normal activities. Reduced ATP production from mitochondrial loss or damage in the wear-and-tear of aging worsens when vascular risk factors (VRF) to Alzheimer's disease develop that can accelerate both age-decline CBF and mitochondrial deficiency to a level where mild cognitive impairment (MCI) develops. To date, no pharmacological or any other treatment has been successful in r…

0301 basic medicinemedicine.medical_specialtyTraumatic brain injuryDiseaseBrain mitochondria03 medical and health sciencesCellular and Molecular NeuroscienceTherapeutic approach0302 clinical medicineInternal medicineMedicineAging brainHumansCognitive DysfunctionCognitive impairmentPharmacologyPhotonsbusiness.industryBrainmedicine.diseaseMitochondria030104 developmental biologyCerebral blood flowBrain stimulationCardiologyLaser Therapybusiness030217 neurology & neurosurgeryNeuropharmacology
researchProduct